Prevpac

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

64 API Suppliers, 23 USDMF, 19 CEP/COS, 16 JDMF, 6 EU WC, 61 KDMF, 13 NDC API, 35 Listed Suppliers

DEVELOPMENTS

20 Drug(s) in Development

20 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Formulations

456 Dossiers, 50 FDA Orange Book, 198 Europe, 26 Canada, 9 Australia, 37 South Africa, 136 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 125MG/5ML, FOR SUSPENSION;ORAL - 250MG/5ML, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 125MG/5ML
FOR SUSPENSION;ORAL - 250MG/5ML
CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 34 Kerry, 28 BASF, 25 Roquette, 16 Seppic, 15 Microlex e.U, 14 Corel Pharma Chem, 13 Gangwal Chemicals, 12 Sigachi Industries, 12 Ideal Cures Pvt Ltd, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Nanjing Well Pharmaceutical, 10 Gangwal Healthcare, 9 SPI Pharma, 9 Actylis, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 5 Prachin Chemical, 4 Pharmatrans-Sanaq, 4 Vasa Pharmachem, 4 Ingredion Pharma Solutions, 3 Jai Radhe Sales, 3 DKSH, 3 Rochem International Inc, 3 Nanjing Bold Chemical, 3 Boai NKY Pharmaceuticals Ltd, 3 Kima Chemical, 2 Clariant, 2 Alcedo Pharmachem, 2 Nomisma Healthcare, 2 Ulanqab Kema New Material, 2 Seqens, 2 Finar, 2 The Dow Chemical Company, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 NEWEDGE Overseas, 1 Pharm-RX Chemical, 1 ACG Worldwide, 1 Evonik, 1 Chynops Pharma, 1 Qualicaps, 1 Pfanstiehl, 1 Lubrizol Life Science Health, 1 Minakem, 1 Vertellus, 1 Avesta Pharma, 1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

72 Coating Systems & Additives, 71 Fillers, Diluents & Binders, 42 Controlled & Modified Release, 35 Solubilizers, 34 Disintegrants & Superdisintegrants, 32 Direct Compression, 31 Thickeners and Stabilizers, 26 Lubricants & Glidants, 25 Granulation, 25 Topical, 21 Parenteral, 19 Film Formers & Plasticizers, 15 Taste Masking, 14 Co-Processed Excipients, 11 Emulsifying Agents, 11 Chewable & Orodispersible Aids, 8 API Stability Enhancers, 7 Surfactant & Foaming Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents